Biofil Chemicals & Pharmaceuticals share news and announcements
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.86down ₹0.18 (0.62%)BSE ₹28.17
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.04.
52-week range of traded prices to 23 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 97.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,19251.9% delivered
Biofil Chemicals & Pharmaceuticals routine notices
155 filed, newest first. Page 2 of 4.
Jan 2024
Dec 2023
Nov 2023
10 Nov · Routine
10 Nov · Routine
8 Nov · Routine
Oct 2023
Sep 2023
Aug 2023
24 Aug · Routine
16 Aug · Routine
Jul 2023
Jun 2023
May 2023
31 May · Routine
Apr 2023
6 Apr · Routine
Mar 2023
23 Mar · Routine
Feb 2023
15 Feb · Routine
Jan 2023
Dec 2022
Nov 2022
16 Nov · Routine
Sep 2022
28 Sep · Routine
6 Sep · Routine
3 Sep · Routine
Aug 2022
10 Aug · Routine
Jul 2022
7 Jul · Routine
Jun 2022
29 Jun · Routine
1 Jun · Routine
Mar 2022
29 Mar · Routine
Feb 2022
16 Feb · Routine
7 Feb · Routine
7 Feb · Routine
Jan 2022
7 Jan · Routine
4 Jan · Routine
Dec 2021
Nov 2021
13 Nov · Routine
Oct 2021
Sep 2021
24 Sep · Routine
3 Sep · Routine
1 Sep · Routine
Aug 2021
20 Aug · Routine
14 Aug · Routine
2 Aug · Routine
2 Aug · Routine
Jul 2021
17 Jul · Routine
8 Jul · Routine